Orthogon Therapeutics: funding roundDevelops antiviral drugs for polyomavirus infectionsOct 4, 2026RoundOSOrthogon TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaUndisclosed